372 related articles for article (PubMed ID: 8238642)
21. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus.
Moxon KA; Gerhardt GA; Gulinello M; Adler LE
Biol Cybern; 2003 Apr; 88(4):247-64. PubMed ID: 12690484
[TBL] [Abstract][Full Text] [Related]
23. Lack of relationship of auditory gating defects to negative symptoms in schizophrenia.
Adler LE; Waldo MC; Tatcher A; Cawthra E; Baker N; Freedman R
Schizophr Res; 1990; 3(2):131-8. PubMed ID: 2278977
[TBL] [Abstract][Full Text] [Related]
24. Early and late auditory sensory gating: moderating influences from schizotypal personality, tobacco smoking status, and acute smoking.
Wan L; Crawford HJ; Boutros N
Psychiatry Res; 2007 May; 151(1-2):11-20. PubMed ID: 17292483
[TBL] [Abstract][Full Text] [Related]
25. Schizophrenia, sensory gating, and nicotinic receptors.
Adler LE; Olincy A; Waldo M; Harris JG; Griffith J; Stevens K; Flach K; Nagamoto H; Bickford P; Leonard S; Freedman R
Schizophr Bull; 1998; 24(2):189-202. PubMed ID: 9613620
[TBL] [Abstract][Full Text] [Related]
26. Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave.
Nagamoto HT; Adler LE; Waldo MC; Griffith J; Freedman R
Schizophr Res; 1991; 4(1):31-40. PubMed ID: 1848997
[TBL] [Abstract][Full Text] [Related]
27. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.
Knott V; Millar A; Fisher D; Albert P
Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902
[TBL] [Abstract][Full Text] [Related]
28. P50 sensory gating and smoking in the general population.
Brinkmeyer J; Mobascher A; Musso F; Schmitz M; Wagner M; Frommann I; Gründer G; Spreckelmeyer KN; Wienker T; Díaz-Lacava A; Holler D; Dahmen N; Thuerauf N; Clepce M; Kiefer F; de Millas W; Gallinat J; Winterer G
Addict Biol; 2011 Jul; 16(3):485-98. PubMed ID: 21392171
[TBL] [Abstract][Full Text] [Related]
29. Auditory sensory processing deficits in sensory gating and mismatch negativity-like responses in the social isolation rat model of schizophrenia.
Witten L; Oranje B; Mørk A; Steiniger-Brach B; Glenthøj BY; Bastlund JF
Behav Brain Res; 2014 Jun; 266():85-93. PubMed ID: 24613239
[TBL] [Abstract][Full Text] [Related]
30. M50 sensory gating predicts negative symptoms in schizophrenia.
Thoma RJ; Hanlon FM; Moses SN; Ricker D; Huang M; Edgar C; Irwin J; Torres F; Weisend MP; Adler LE; Miller GA; Canive JM
Schizophr Res; 2005 Mar; 73(2-3):311-8. PubMed ID: 15653276
[TBL] [Abstract][Full Text] [Related]
31. Baseline dependency of nicotine's sensory gating actions: similarities and differences in low, medium and high P50 suppressors.
Knott V; de la Salle S; Smith D; Phillipe T; Dort H; Choueiry J; Impey D
J Psychopharmacol; 2013 Sep; 27(9):790-800. PubMed ID: 23744798
[TBL] [Abstract][Full Text] [Related]
32. Neurobiological studies of sensory gating in schizophrenia.
Freedman R; Adler LE; Gerhardt GA; Waldo M; Baker N; Rose GM; Drebing C; Nagamoto H; Bickford-Wimer P; Franks R
Schizophr Bull; 1987; 13(4):669-78. PubMed ID: 2894074
[TBL] [Abstract][Full Text] [Related]
33. [P50 sensory gating disorders of auditory evoked potentials (AEP) in persons with schizophrenia].
Wegrzyn J
Psychiatr Pol; 2004; 38(5):833-45. PubMed ID: 15523930
[TBL] [Abstract][Full Text] [Related]
34. P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients.
Turetsky BI; Dent G; Jaeger J; Zukin SR
Psychopharmacology (Berl); 2012 May; 221(1):39-52. PubMed ID: 22048129
[TBL] [Abstract][Full Text] [Related]
35. Yohimbine impairs P50 auditory sensory gating in normal subjects.
Adler LE; Hoffer L; Nagamoto HT; Waldo MC; Kisley MA; Giffith JM
Neuropsychopharmacology; 1994 Jul; 10(4):249-57. PubMed ID: 7945735
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors.
Knott VJ; Fisher DJ; Millar AM
Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model.
Freedman R; Adler LE; Myles-Worsley M; Nagamoto HT; Miller C; Kisley M; McRae K; Cawthra E; Waldo M
Arch Gen Psychiatry; 1996 Dec; 53(12):1114-21. PubMed ID: 8956677
[TBL] [Abstract][Full Text] [Related]
38. Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats.
Stevens KE; Meltzer J; Rose GM
Psychopharmacology (Berl); 1995 May; 119(2):163-70. PubMed ID: 7659763
[TBL] [Abstract][Full Text] [Related]
39. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
Siegel SJ; Maxwell CR; Majumdar S; Trief DF; Lerman C; Gur RE; Kanes SJ; Liang Y
Neuroscience; 2005; 133(3):729-38. PubMed ID: 15908134
[TBL] [Abstract][Full Text] [Related]
40. Rats reared in social isolation show schizophrenia-like changes in auditory gating.
Stevens KE; Johnson RG; Rose GM
Pharmacol Biochem Behav; 1997 Dec; 58(4):1031-6. PubMed ID: 9408210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
